<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03717948</url>
  </required_header>
  <id_info>
    <org_study_id>BFRNP</org_study_id>
    <secondary_id>402635</secondary_id>
    <nct_id>NCT03717948</nct_id>
  </id_info>
  <brief_title>Examining the Impact of Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males</brief_title>
  <official_title>Examining the Impact of Acute Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males: A Randomized Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen's University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This crossover study investigates the effects of restricting arterial blood flow during
      cycling exercise on PGC-1α and its upstream signalling pathways. In a randomized order,
      participants will exercise once for 30 minutes with restricted blood flow and then will
      exercise once for 30 minutes with no blood flow restriction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">January 28, 2019</completion_date>
  <primary_completion_date type="Actual">January 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Allocation concealment, assessor blinding</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA)</measure>
    <time_frame>15 minutes before exercise and 3 hours post-exercise for both exercise sessions</time_frame>
    <description>Fold-change in PGC-1α mRNA expression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Catecholamine concentrations</measure>
    <time_frame>15 minutes before exercise and immediately post-exercise for both exercise sessions</time_frame>
    <description>Catecholamine concentrations in venous blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total and phosphorylated p38 mitogen-activated protein kinase (MAPK)</measure>
    <time_frame>15 minutes before exercise and immediately post-exercise for both exercise sessions</time_frame>
    <description>Fold change in p38 MAPK phosphorylation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total and phosphorylated acetyl coenzyme A carboxylase (ACC)</measure>
    <time_frame>15 minutes before exercise and immediately post-exercise for both exercise sessions</time_frame>
    <description>Fold change in ACC phosphorylation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total and phosphorylated protein kinase A (PKA)</measure>
    <time_frame>15 minutes before exercise and immediately post-exercise for both exercise sessions</time_frame>
    <description>Fold change in PKA phosphorylation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acetylated p53</measure>
    <time_frame>15 minutes before exercise and immediately post-exercise for both exercise sessions</time_frame>
    <description>Fold change in acetylated p53</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lactate</measure>
    <time_frame>During both exercise sessions (lactate); 15 minutes before and immediately after both exercise sessions</time_frame>
    <description>Average [lactate] between conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate (HR)</measure>
    <time_frame>During both exercise sessions</time_frame>
    <description>Average HR between conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revolutions per minute (RPM)</measure>
    <time_frame>During both exercise sessions</time_frame>
    <description>Average RPM between conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratings of perceived exertion (RPE)</measure>
    <time_frame>During both exercise sessions</time_frame>
    <description>Average RPE between conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygenated and deoxygenated hemoglobin</measure>
    <time_frame>During both exercise sessions and up to 10 minutes after (for cuff occlusion)</time_frame>
    <description>Average oxygenated and deoxygenated hemoglobin as a percentage of same day max values</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Mitochondrial Biogenesis</condition>
  <arm_group>
    <arm_group_label>CTL - BFR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CTL Exercise then BFR Exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BFR - CTL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BFR Exercise then CTL Exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BFR Exercise</intervention_name>
    <description>Participants will exercise on a recumbent bike placed on a 45 degree incline (BFR).</description>
    <arm_group_label>BFR - CTL</arm_group_label>
    <arm_group_label>CTL - BFR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CTL Exercise</intervention_name>
    <description>Participants will exercise on a recumbent bike placed on flat ground (CTL).</description>
    <arm_group_label>BFR - CTL</arm_group_label>
    <arm_group_label>CTL - BFR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  3 hours of physical activity per week

          -  No previous cycling training

          -  No concurrent involvement in another training program

          -  Body mass index &lt; 30 kg/m2

        Exclusion Criteria:

          -  Presence of cardiovascular disease

          -  Presence of metabolic disease

          -  Taking regular oral medication

          -  Current smoker
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brendon J Gurd, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen's University</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L3N6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 19, 2018</study_first_submitted>
  <study_first_submitted_qc>October 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2018</study_first_posted>
  <last_update_submitted>July 11, 2019</last_update_submitted>
  <last_update_submitted_qc>July 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University</investigator_affiliation>
    <investigator_full_name>Brendon Gurd</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Acute Exercise</keyword>
  <keyword>Mitochondria</keyword>
  <keyword>Skeletal Muscle</keyword>
  <keyword>PGC1α</keyword>
  <keyword>Mitochondrial Biogenesis</keyword>
  <keyword>Intracellular Signalling</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 24, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/48/NCT03717948/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

